Lenalidomide intermediate preparation method
Patent Information
- Authority / Receiving Office
- CN ยท China
- Current Assignee / Owner
- SHANGHAI TIANCI BIOLOGICAL VALLEY BIOLOGICAL ENG
- Publication Date
- 2016-04-27
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the field of synthesis of chemical drugs, in particular to a 3-(4-amino-1-oxo-1,3-dihydro-2H-isozainden-2-yl)piperidine-2, The preparation process of the important intermediate 2-bromomethyl-3-nitrobenzoate methyl ester (compound of formula I) of 6-diketone (lenalidomide). Background technique
[0002] Multiple myeloma (Multiplemgeloma, MM) is a refractory malignant B-cell disease, in patients with bone marrow malignant cells continue to proliferate, making normal cells unable to function. Myelodysplastic syndrome (myelodysplastic syndrome, MDS) is a clonal hematopoietic neoplasm. Myelodysplastic syndrome occurs when blood cells in the bone marrow are always in the immature stage and cannot perform their necessary functions. The bone marrow is full of these immature cells. Inhibits the development of normal cells. Chemotherapy for MM and MDS began in the 1960s. In the following 30 years, melphalan combined with predni...